Prognostic value of urinary 11-dehydro-thromboxane B2 for mortality: A cohort study of stable coronary artery disease patients treated with aspirin.

Kristen M TecsonKristen M TecsonJeanna Bennett-FirminTeodoro BottiglieriLuis R LopezMargarita PetersonMohanakrishnan SathyamoorthyRaphael SchiffmannJeffrey M SchusslerCaren SwiftCarlos E VelascoPeter A McCullough

Published in: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions (2017)

Our data indicate the optimal cut point for urine 11dhTxB2 is 1597.8 (pg/mg) for the risk prediction of mortality over five years in stable patients with CAD patients treated with aspirin.

Keyphrases

cardiovascular events
coronary artery disease
low dose
percutaneous coronary intervention
coronary artery bypass grafting
cardiovascular disease
antiplatelet therapy
risk factors
electronic health record
big data
type diabetes
heart failure
acute coronary syndrome